Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

Clinical trial NCT05156320 · COMPLETED

Trial details

NCT number: NCT05156320
Sponsor: Scholar Rock, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Spinal Muscular Atrophy Spinal Muscular Atrophy Type 3 Spinal Muscular Atrophy Type 2 SMA Neuromuscular Diseases Muscular Atrophy Atrophy Muscular Atrophy, Spinal Neuromuscular Manifestations Anti-myostatin

Start date: 2022-04-14
Primary completion: 2024-12-18
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.